SRL172

Known as: SRL 172 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2016
02419982016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Two studies were carried out to evaluate heat-killed Mycobacterium vaccae SRL172 as an immunotherapeutic agent for patients with… (More)
Is this relevant?
2004
2004
BACKGROUND This open-label, randomised phase III study was designed to further investigate the clinical activity and safety of… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2003
2003
We conducted a randomized phase II trial of SRL172 (Mycobacterium vaccae) +/- low-dose interleukin-2 (IL-2) as treatment for… (More)
Is this relevant?
2002
2002
BACKGROUND Mortality rates of HIV-infected patients treated for tuberculosis remain high. This study aimed to assess the effect… (More)
  • table 2
  • figure 1
  • table 1
  • table 3
  • figure 2
Is this relevant?
2002
2002
The objectives of this study were to determine the toxicity of intratumoural/intrapleural SRL172 in addition to intradermal… (More)
  • table 3
  • table 1
  • table 4
  • table 2
  • figure 1
Is this relevant?
2002
2002
BACKGROUND SRL172 is a suspension of heat killed Mycobacterium vaccae, that has been found to be a potent immunological adjuvant… (More)
Is this relevant?
2000
2000
Mycobacterial preparations have been used with limited success against cancer apart from superficial bladder cancer. Recently, a… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
2000
2000
Periodontal disease is a bacterial dental plaque-induced destructive inflammatory condition of the tooth-supporting tissues… (More)
Is this relevant?
1998
1998
OBJECTIVE To assess whether a new heat-killed Mycobacterium vaccae preparation (SRL172), which enhances cell-mediated immunity… (More)
Is this relevant?
1998
1998
OBJECTIVE To evaluate the potential of heat-killed Mycobacterium vaccae (SRL172) as a nonspecific immunostimulant and as an… (More)
Is this relevant?